GSK

GSK joins other drugmakers recalling Zantac products
GSK joins other drugmakers recalling Zantac products
Fierce Pharma
GSK
ranitidine
product recalls
OTC
Flag link:
GSK's ViiV launches first campaign for new HIV med Dovato with real patient ambassadors
GSK's ViiV launches first campaign for new HIV med Dovato with real patient ambassadors
Fierce Pharma
GSK
ViiV Healthcare
Dovato
DTC ads
HIV
Flag link:
GSK, Innoviva file sNDA to seek US approval for Trelegy Ellipta in asthma
GSK, Innoviva file sNDA to seek US approval for Trelegy Ellipta in asthma
Pharmaceutical Business Review
GSK
Innoviva
Trelegy Ellipta
asthma
Flag link:
GSK’s Walmsley backs #MeTooPay gender pay campaign
GSK’s Walmsley backs #MeTooPay gender pay campaign
Pharmaforum
GSK
Pharma CEOs
Emma Walmsley
gender gap
Flag link:
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
ESMO
PARP inhibitors
prostate cancer
KRAS
Seattle Genetics
AstraZeneca
Merck
GSK
Amgen
breast cancer
Roche
Pfizer
Flag link:
GlaxoSmithKline's Nucala cuts severe asthma attacks in 'reassuring' interim real-world data
GlaxoSmithKline's Nucala cuts severe asthma attacks in 'reassuring' interim real-world data
Fierce Pharma
GSK
Nucala
severe asthma
real world data
Flag link:
GSK’s niraparib meets PFS goal in phase 3 PRIMA trial
GSK’s niraparib meets PFS goal in phase 3 PRIMA trial
Pharmaceutical Business Review
GSK
clinicial trials
niraparib
Zejula
advanced ovarian cancer
Flag link:
Separate GSK, AstraZeneca trial results may widen ovarian cancer drug use
Separate GSK, AstraZeneca trial results may widen ovarian cancer drug use
Yahoo/Reuters
GSK
AstraZeneca
ESMO
ovarianc cancer
PARP inhibitors
Lynparza
Zejula
Flag link:
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
Flag link:
GSK and AstraZeneca's PARP Inhibitors Will Flex Their Muscles at ESMO
GSK and AstraZeneca's PARP Inhibitors Will Flex Their Muscles at ESMO
BioSpace
GSK
AstraZeneca
PARP inhibitors
ESMO
Lynparza
Zejula
Flag link:
GlaxoSmithKline halts generic Zantac supply as global threat gains steam
GlaxoSmithKline halts generic Zantac supply as global threat gains steam
Fierce Pharma
Novartis
GSK
generics
OTC
Zantac
product recalls
Flag link:
GSK invests $120M in biopharma plant as renewed oncology bets grow
GSK invests $120M in biopharma plant as renewed oncology bets grow
Fierce Pharma
GSK
biologics
oncology
drug manufacturing
Flag link:
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Endpoints
GSK
ViiV
Tivicay
HIV
HemoShear
Flag link:
Malaria Vaccine 30 Years And $1 Billion In The Making Now Deployed In Third Country
Malaria Vaccine 30 Years And $1 Billion In The Making Now Deployed In Third Country
Forbes
Africa
malaria
vaccines
GSK
Gates Foundation
Malawi
Ghana
Kenya
Flag link:
The Week Ahead In Biotech: Spotlight On ESMO Conference
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
Flag link:
HIV vaccine shows signs of cross-subtype protection
HIV vaccine shows signs of cross-subtype protection
Fierce Biotech
vaccines
HIV
ALVAC‐HIV
Sanofi Pasteur
GSK
JNJ
South Africa
clinical trials
Flag link:
Microsoft nominates GSK CEO Walmsley to board
Microsoft nominates GSK CEO Walmsley to board
Yahoo/Reuters
Microsoft
GSK
Pharma CEOs
Emma Walmsley
Flag link:
GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks
GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks
Fierce Pharma
GSK
FDA
advisory panels
OTC
Flag link:
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Yahoo/Zacks.com
GSK
Nucala
eosinophilic asthma
pediatrics
FDA
Flag link:
Who joins Purdue on pharma's top settlements list? Merck, GSK and Pfizer, for starters
Who joins Purdue on pharma's top settlements list? Merck, GSK and Pfizer, for starters
Fierce Pharma
Purdue Pharma
legal
Merck
GSK
Pfizer
Flag link:

Pages